BAESWEILER, GERMANY -- (MARKET WIRE) -- September 25, 2006 -- AplaGen GmbH and Bayer HealthCare AG Animal Health have signed an agreement for the evaluation, development and marketing of several therapeutic peptides from the AplaGen pipeline. The peptides will be used in the veterinary field only.
